According to Bloomberg, Roche Holding AG owns about 60% of Chugai Pharmaceuticals Co., Ltd. and is now attempting to buyout the remaining 40%. At present, the deal is estimated to be around $10 billion. Chugai and Roche are currently partnering for oncology and arthritis treatments. Chugai denies that buyout talks are taking place.
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.